Do not take PDE5 inhibitors, which include sildenafil, tadalafil, vardenafil, and avanafil, with any nitrate in any form. Nitrates cover prescription nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, and recreational nitrites known as poppers. The combination can cause a dangerous drop in blood pressure, and most labels advise waiting at least 24 hours after shorter acting ED drugs or at least 48 hours after tadalafil. If you develop chest pain, dizziness, or fainting after taking both, call emergency services and tell them you took an ED drug.
TL;DR:
- Men taking daily nitrates for angina are usually at risk of dangerous blood pressure drops if they use PDE5 inhibitors, which should generally be avoided or discussed with a doctor.
- The waiting period after ED drugs varies: at least 24 hours for sildenafil, vardenafil, and avanafil, and 48 hours for tadalafil, but factors like age and liver function can extend these times.
- Combining nitrates and PDE5 inhibitors consistently causes additive vasodilation, leading to potentially life-threatening hypotension and increased cardiovascular mortality.
- Alternative ED treatments not involving the nitric oxide pathway, such as vacuum devices or injections, are safer options for men who must stay on nitrates.
- Regular medication review with a healthcare professional, especially cardiology input, can help some patients safely deprescribe nitrates and resume PDE5 inhibitor therapy.
Nitrates relax blood vessels to relieve chest pain from angina, and doctors prescribe them in several forms depending on how fast a patient needs relief. Nitroglycerin is the most common, and it comes as a sublingual spray or tablet for sudden chest pain, plus a longer acting patch or ointment for daily prevention. Isosorbide mononitrate and isosorbide dinitrate are oral tablets used for ongoing angina control rather than emergencies.
The form matters because it changes how long the drug stays active in your system, and that duration directly affects how long the interaction risk lasts.
Poppers deserve special mention because many men do not think of them as medication. They are still nitrites, and combining them with an ED drug carries the same risk as combining a prescription nitrate, even though nobody wrote a prescription for either one. A patch worn for 12 hours creates a longer window of risk than a sublingual tablet taken once, which is one reason clinicians ask specifically about patches and ointments, not just pills, when they screen for interactions.
Sildenafil, tadalafil, vardenafil, and avanafil all belong to a class called PDE5 inhibitors, and they work by blocking an enzyme that normally breaks down a molecule called cGMP. More cGMP means more relaxed blood vessels in the penis, which is how these drugs produce an erection. The same nitric oxide and cGMP pathway that nitrates use to relax blood vessels elsewhere in the body gets amplified by PDE5 inhibitors, and that shared mechanism is exactly why the two drug types conflict.
Plasma sildenafil may remain measurable up to 24 hours after a dose, and levels can be higher in older adults or those with liver or kidney impairment. According to the sildenafil label, which is one reason a fixed waiting period does not fit every patient equally.
Several factors stretch that risk window further than the label’s standard timing. Age slows drug clearance, and impaired liver or kidney function does the same. Potent CYP3A4 inhibitors, a category that includes some antifungal and antiviral drugs, slow the breakdown of PDE5 inhibitors and can leave meaningful drug levels in the blood well past the usual cutoff.
Both nitrates and PDE5 inhibitors push the same biological lever, and pushing it twice at once is the problem. Nitrates release nitric oxide directly, while PDE5 inhibitors block the enzyme that normally clears the cGMP that nitric oxide produces. Taken together, the two effects stack, and blood vessels throughout the body relax far more than either drug would cause alone. The result can be a steep, sometimes prolonged, drop in blood pressure that starves the heart and brain of blood flow.
Early pharmacology work established how severe this effect can be. Human and animal hemodynamic studies documented large decreases in systemic blood pressure and reduced coronary blood flow when sildenafil was combined with nitrates, confirming the interaction is not just theoretical.
The concern extends beyond a single dangerous episode. A large observational study covering more than 60,000 men with stable coronary artery disease found that those with combined prescriptions for PDE5 inhibitors and nitrates had higher long-term cardiovascular and all-cause mortality than men prescribed only one of the two drug types.
Nitrates should not be administered to patients who recently received a phosphodiesterase inhibitor.
That guidance comes from the 2014 AHA/ACC guideline for managing acute coronary syndromes, and it reflects the same contraindication printed on every PDE5 inhibitor label. “Contraindicated” here means the combination is not a matter of caution or dose adjustment: it is a use that prescribing information and cardiology guidelines say should not happen.
| Drug pathway | Effect | Result when combined |
|---|---|---|
| Nitrates | Release nitric oxide directly | Vasodilation |
| PDE5 inhibitors | Block cGMP breakdown | Amplified vasodilation |
| Combined | Additive nitric oxide and cGMP signaling | Marked, sometimes prolonged hypotension |
Prescribing labels give specific spacing windows, but they are guidelines built for typical patients, not guarantees for every body. The standard advice separates by which PDE5 inhibitor you took.
Pro Tip: Keep an updated medication list on your phone, including any ED drug and its last dose time, so you or emergency responders can act fast if something goes wrong.
Emergency medicine occasionally has to break its own rule. If a patient with recent PDE5 inhibitor use develops life-threatening chest pain, the AHA/ACC guideline allows clinicians to weigh nitrate use against the risk of untreated ischemia, under close blood pressure monitoring and with fluids or vasopressors ready if hypotension follows. That decision belongs to a treating physician in a monitored setting, never to a patient at home.
Not every man faces the same risk from this interaction, and a few groups need a more careful conversation before starting or continuing either drug type.
Cardiology groups have started pushing back on the assumption that nitrate use is permanent. The Princeton IV Consensus and related ACC commentary recommend that physicians reassess whether chronic nitrate therapy is still necessary for some patients, since many carry a nitroglycerin prescription they rarely use. Those patients can sometimes taper off nitrates or switch to another antianginal drug under cardiology supervision, opening the door to safer ED treatment.
If nitrates appear on your medication list, bring that list to your primary care visit and ask directly whether deprescribing is worth exploring. A cardiology referral before starting a PDE5 inhibitor is a reasonable ask, not an overreaction.
A small number of men will end up in this situation despite every precaution, so knowing the sequence of actions matters as much as knowing the rule.
Most men who report this combination promptly and get monitored recover without lasting harm, but the outcome depends heavily on how fast the drop in blood pressure gets caught and treated. Honesty with the emergency team, not silence out of embarrassment, is what makes that fast response possible.
Men who need nitrates for genuine angina control are not out of options for treating ED, they just need a different toolkit than a pill.
Pro Tip: Ask your prescriber whether your nitrate is truly a daily necessity or a leftover “just-in-case” prescription. Some men qualify for supervised deprescribing, which reopens the door to PDE5 inhibitors.
Beyond drug swaps, medication reconciliation with your care team catches interactions before they become emergencies, and cardiology review can identify whether another antianginal drug could replace a nitrate entirely. Lifestyle changes such as regular exercise, quitting smoking, and managing weight support both erectile function and cardiovascular health at the same time, and they carry zero interaction risk with anything else you take. More detail on those changes is available in our guide to lifestyle changes for ED recovery.
A telehealth visit built around a full medication review is one practical way to sort out whether ED treatment is safe for you. Online clinician visits include medication reconciliation, so a nitrate on your list gets flagged and discussed before any prescription is written, not after. When a clinician sees a nitrate, a recent cardiac event, or another red flag, the appropriate response is referral to cardiology rather than a workaround.
Telehealth has real limits here. Complex cardiac instability, unstable angina, or active chest pain need in-person cardiology and emergency evaluation, not a video visit. This service is built for assessment and supervised outpatient management once a patient is medically stable, with prescription delivery and ongoing app-based follow-up support for men who are cleared to proceed. More on how that consultation process works is available in our ED medication side effects guide.
Treating ED matters for quality of life, and the evidence suggests many cardiac patients can be treated safely once nitrates are no longer part of their daily regimen. The mistake is treating every man on a nitrate as permanently ineligible for ED treatment, when a fair number could be candidates for deprescribing under the right supervision.
The bigger gap is coordination. Primary care, cardiology, and sexual health providers too often work in isolation, leaving patients to piece together conflicting advice on their own. Shared decision-making and a regular medication review should be the default, not the exception, and the field would benefit from more research tracking long-term outcomes for men who move safely off chronic nitrates.
— Bryan
Sorting out whether an ED drug is safe for you starts with someone actually looking at your full medication list, not guessing from a form. That review is built into every ED consultation, so a nitrate, a heart history, or a kidney concern gets caught before a prescription ships.
Getting started is simple:
Start with our ED consultation checklist to see what a visit involves, or head straight to the ED treatment page to begin your assessment today.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
No. Tadalafil, sold as Cialis, carries the same nitrate contraindication as every other PDE5 inhibitor, and its longer duration is why many clinicians recommend waiting at least 48 hours after a dose before using any nitrate, according to the tadalafil prescribing information.
Viagra, or sildenafil, and nitrates both relax blood vessels through the same nitric oxide and cGMP pathway, so combining them can cause a severe, sometimes prolonged drop in blood pressure. The sildenafil label lists this combination as contraindicated for that reason.
Traditional Chinese medicine has historically used various herbal preparations for sexual health concerns, but these approaches are not standardized or FDA regulated, and none have the clinical trial backing that PDE5 inhibitors have. Anyone considering an herbal product should still disclose it to a clinician, since some herbal supplements can affect blood pressure or interact with prescription medications.
Regular aerobic exercise, quitting smoking, and maintaining a healthy weight all support blood vessel health and can improve erectile function over time. These lifestyle changes work alongside, not instead of, any medical treatment your clinician recommends, and they carry no interaction risk with nitrates or PDE5 inhibitors.
Yes. Vacuum erection devices, intracavernosal injections, and intraurethral suppositories all treat ED without the nitric oxide pathway that PDE5 inhibitors use, making them options for men who cannot safely stop their nitrate. A cardiology review can also determine whether some patients qualify for supervised deprescribing, which may reopen the door to PDE5 inhibitors later.
.svg)
